What is Zacks Research’s Estimate for MTD Q1 Earnings?

Mettler-Toledo International Inc. (NYSE:MTD) – Research analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for Mettler-Toledo International in a note issued to investors on Monday, January 6th. Zacks Research analyst R. Department now expects that the medical instruments supplier will earn $8.42 per share for the quarter, down from their previous estimate of $8.78. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.25 EPS, FY2025 earnings at $41.94 EPS, Q1 2026 earnings at $9.97 EPS, Q2 2026 earnings at $11.03 EPS and FY2026 earnings at $48.62 EPS.

Other research analysts also recently issued reports about the company. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Finally, Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Trading Down 0.8 %

Shares of NYSE MTD opened at $1,245.45 on Wednesday. The company’s 50-day moving average price is $1,253.23 and its 200 day moving average price is $1,350.06. Mettler-Toledo International has a 52 week low of $1,122.21 and a 52 week high of $1,546.93. The stock has a market cap of $26.28 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 4.21 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently bought and sold shares of MTD. Caprock Group LLC raised its stake in shares of Mettler-Toledo International by 68.8% in the 2nd quarter. Caprock Group LLC now owns 508 shares of the medical instruments supplier’s stock worth $710,000 after buying an additional 207 shares in the last quarter. Ballentine Partners LLC lifted its holdings in Mettler-Toledo International by 13.9% in the 2nd quarter. Ballentine Partners LLC now owns 600 shares of the medical instruments supplier’s stock valued at $839,000 after acquiring an additional 73 shares during the last quarter. Oak Thistle LLC lifted its stake in Mettler-Toledo International by 46.2% during the second quarter. Oak Thistle LLC now owns 326 shares of the medical instruments supplier’s stock valued at $456,000 after purchasing an additional 103 shares during the last quarter. Quest Partners LLC boosted its holdings in Mettler-Toledo International by 1,650.0% during the second quarter. Quest Partners LLC now owns 105 shares of the medical instruments supplier’s stock worth $147,000 after buying an additional 99 shares in the last quarter. Finally, Prudential PLC grew its position in Mettler-Toledo International by 3.6% in the second quarter. Prudential PLC now owns 2,535 shares of the medical instruments supplier’s stock worth $3,543,000 after buying an additional 87 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.